Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

Evaluation of a hybrid capture-based pan-cancer panel for analysis of treatment stratifying oncogenic aberrations and processes.

Kroeze LI, de Voer RM, Kamping EJ, von Rhein D, Jansen EAM, Hermsen MJW, Barberis MCP, Botling J, Garrido-Martin EM, Haller F, Lacroix L, Maes B, Merkelbach-Bruse S, Pestinger V, Pfarr N, Stenzinger A, van den Heuvel MM, Grünberg K, Ligtenberg MJL.

J Mol Diagn. 2020 Mar 20. pii: S1525-1578(20)30054-4. doi: 10.1016/j.jmoldx.2020.02.009. [Epub ahead of print]

PMID:
32205293
2.

Correlation among different KRAS alterations, genetic co-mutations and PD-L1 expression in patients treated with immunotherapy in metastatic NSCLC.

Gianoncelli L, Spitaleri G, Passaro A, Fumagalli C, Trillo Aliaga P, Del Signore E, Stati V, Ferraro E, Guerini-Rocco E, Catania CM, Barberis M, de Marinis F.

Ann Oncol. 2019 Apr;30 Suppl 2:ii57. doi: 10.1093/annonc/mdz063.050. No abstract available.

3.

Clinical and treatment features associated with improved 5-year survival rate in ALK-positive lung cancer treated with ALK-TKIs.

Passaro A, Prelaj A, Spitaleri G, Del Signore E, Rossi G, Guerini-Rocco E, Barberis M, Catania C, de Marinis F.

Ann Oncol. 2019 Apr;30 Suppl 2:ii54. doi: 10.1093/annonc/mdz063.042. No abstract available.

4.

Complex Stability and an Irrevertible Transition Reverted by Peptide and Fibroblasts in a Dynamic Model of Innate Immunity.

Abudukelimu A, Barberis M, Redegeld F, Sahin N, Sharma RP, Westerhoff HV.

Front Immunol. 2020 Feb 14;10:3091. doi: 10.3389/fimmu.2019.03091. eCollection 2019.

5.

When Right Is on the Left (and Vice Versa): A Case Series of Glioma Patients with Reversed Lateralization of Cognitive Functions.

Mandonnet E, Mellerio C, Barberis M, Poisson I, Jansma JM, Rutten GJ.

J Neurol Surg A Cent Eur Neurosurg. 2020 Mar;81(2):138-146. doi: 10.1055/s-0040-1701625. Epub 2020 Feb 17.

PMID:
32066189
6.

Broad-based genomic sequencing in advanced non-small cell lung cancer in the dock.

Fumagalli C, Guerini-Rocco E, Barberis M.

Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S360-S363. doi: 10.21037/tlcr.2019.04.16. No abstract available.

7.

Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast.

Lazzeroni M, DeCensi A, Guerrieri-Gonzaga A, Pagan E, Bagnardi V, Macis D, Serrano D, Vingiani A, Bonizzi G, Barberis M, Pruneri G, Wagner S, Gandini S, Viale G, Bonanni B.

Mod Pathol. 2020 Jan 10. doi: 10.1038/s41379-020-0452-0. [Epub ahead of print]

PMID:
31925342
8.

A case of Warthin-like papillary thyroid carcinoma with diffuse sclerosing stroma and a novel RET mutation: a new entity or a combined tumour?

Maffini F, Lorenzini D, Lepanto D, De Fiori E, Fumagalli C, Rappa A, Tagliabue M, Barberis M.

Ecancermedicalscience. 2019 Oct 2;13:965. doi: 10.3332/ecancer.2019.965. eCollection 2019.

9.

ALS phenotype is influenced by age, sex, and genetics: A population-based study.

Chiò A, Moglia C, Canosa A, Manera U, D'Ovidio F, Vasta R, Grassano M, Brunetti M, Barberis M, Corrado L, D'Alfonso S, Iazzolino B, Peotta L, Sarnelli MF, Solara V, Zucchetti JP, De Marchi F, Mazzini L, Mora G, Calvo A.

Neurology. 2020 Feb 25;94(8):e802-e810. doi: 10.1212/WNL.0000000000008869. Epub 2020 Jan 6.

PMID:
31907290
10.

Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective Analysis.

Gianoncelli L, Spitaleri G, Passaro A, Radice D, Fumagalli C, Del Signore E, Stati V, Catania CM, Guerini-Rocco E, Barberis M, DE Marinis F.

Anticancer Res. 2020 Jan;40(1):427-433. doi: 10.21873/anticanres.13970.

PMID:
31892597
11.

Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraints.

Winneroski LL, Erickson JA, Green SJ, Lopez JE, Stout SL, Porter WJ, Timm DE, Audia JE, Barberis M, Beck JP, Boggs LN, Borders AR, Boyer RD, Brier RA, Hembre EJ, Hendle J, Garcia-Losada P, Minguez JM, Mathes BM, May PC, Monk SA, Rankovic Z, Shi Y, Watson BM, Yang Z, Mergott DJ.

Bioorg Med Chem. 2020 Jan 1;28(1):115194. doi: 10.1016/j.bmc.2019.115194. Epub 2019 Nov 15.

PMID:
31786008
12.

Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy.

Fumagalli C, Tomao F, Betella I, Rappa A, Calvello M, Bonanni B, Bernard L, Peccatori F, Colombo N, Viale G, Barberis M, Guerini-Rocco E.

Cancers (Basel). 2019 Oct 24;11(11). pii: E1641. doi: 10.3390/cancers11111641.

13.

The challenge of overcoming the language barrier for brain tumor awake surgery in migrants: a feasibility study in five patient cases.

Aubrun S, Poisson I, Barberis M, Draou C, Toure M, Madadaki C, Froelich S, Gayat E, Mandonnet E.

Acta Neurochir (Wien). 2020 Feb;162(2):389-395. doi: 10.1007/s00701-019-04101-1. Epub 2019 Oct 25.

PMID:
31650333
14.
15.

BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories.

Capoluongo E, La Verde N, Barberis M, Bella MA, Buttitta F, Carrera P, Colombo N, Cortesi L, Gion M, Guarneri V, Lorusso D, Marchetti A, Marchetti P, Normanno N, Pasini B, Pensabene M, Pignata S, Radice P, Ricevuto E, Sapino A, Tagliaferri P, Tassone P, Trevisiol C, Truini M, Varesco L, Russo A, Gori S.

Diagnostics (Basel). 2019 Oct 9;9(4). pii: E146. doi: 10.3390/diagnostics9040146.

16.

Next-generation sequencing-based BRCA testing on cytological specimens from ovarian cancer ascites reveals high concordance with tumour tissue analysis.

Fumagalli C, Rappa A, Casadio C, Betella I, Colombo N, Barberis M, Guerini-Rocco E.

J Clin Pathol. 2020 Mar;73(3):168-171. doi: 10.1136/jclinpath-2019-206127. Epub 2019 Sep 19.

PMID:
31537627
17.

Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy.

Passaro A, Mancuso P, Gandini S, Spitaleri G, Labanca V, Guerini-Rocco E, Barberis M, Catania C, Del Signore E, de Marinis F, Bertolini F.

Clin Transl Oncol. 2020 Apr;22(4):621. doi: 10.1007/s12094-019-02198-5.

PMID:
31432394
18.

Cognitive impairment across ALS clinical stages in a population-based cohort.

Chiò A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, Barberis M, Corrado L, D'Alfonso S, Bersano E, Sarnelli MF, Solara V, Zucchetti JP, Peotta L, Iazzolino B, Mazzini L, Mora G, Calvo A.

Neurology. 2019 Sep 3;93(10):e984-e994. doi: 10.1212/WNL.0000000000008063. Epub 2019 Aug 13.

19.

ChIP-exo analysis highlights Fkh1 and Fkh2 transcription factors as hubs that integrate multi-scale networks in budding yeast.

Mondeel TDGA, Holland P, Nielsen J, Barberis M.

Nucleic Acids Res. 2019 Sep 5;47(15):7825-7841. doi: 10.1093/nar/gkz603.

20.

Analysis of the GCG repeat length in NIPA1 gene in C9orf72-mediated ALS in a large Italian ALS cohort.

Corrado L, Brunetti M, Di Pierro A, Barberis M, Croce R, Bersano E, De Marchi F, Zuccalà M, Barizzone N, Calvo A, Moglia C, Mazzini L, Chiò A, D'Alfonso S.

Neurol Sci. 2019 Dec;40(12):2537-2540. doi: 10.1007/s10072-019-04001-3. Epub 2019 Jul 9.

PMID:
31286297
21.

Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy.

Passaro A, Mancuso P, Gandini S, Spitaleri G, Labanca V, Guerini-Rocco E, Barberis M, Catania C, Del Signore E, de Marinis F, Bertolini F.

Clin Transl Oncol. 2020 Apr;22(4):603-611. doi: 10.1007/s12094-019-02166-z. Epub 2019 Jun 28. Erratum in: Clin Transl Oncol. 2019 Aug 20;:.

PMID:
31254252
22.

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.

Gori S, Barberis M, Bella MA, Buttitta F, Capoluongo E, Carrera P, Colombo N, Cortesi L, Genuardi M, Gion M, Guarneri V, Incorvaia L, La Verde N, Lorusso D, Marchetti A, Marchetti P, Normanno N, Pasini B, Pensabene M, Pignata S, Radice P, Ricevuto E, Sapino A, Tagliaferri P, Tassone P, Trevisiol C, Truini M, Varesco L, Russo A; AIOM-SIGU-SIBIOC-SIAPEC-IAP Working Group.

Crit Rev Oncol Hematol. 2019 Aug;140:67-72. doi: 10.1016/j.critrevonc.2019.05.012. Epub 2019 May 25.

23.

Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens.

Pisapia P, Malapelle U, Roma G, Saddar S, Zheng Q, Pepe F, Bruzzese D, Vigliar E, Bellevicine C, Luthra R, Nikiforov YE, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Bihl M, Savic S, Bubendorf L, de Biase D, Tallini G, Hwang DH, Sholl LM, Vander Borght S, Weynand B, Stieber D, Vielh P, Rappa A, Barberis M, Fassan M, Rugge M, De Andrea CE, Lozano MD, Lupi C, Fontanini G, Schmitt F, Dumur CI, Bisig B, Bongiovanni M, Merkelbach-Bruse S, Büttner R, Nikiforova MN, Roy-Chowdhuri S, Troncone G; Molecular Cytopathology Meeting Group.

Cancer Cytopathol. 2019 May;127(5):285-296. doi: 10.1002/cncy.22134. Epub 2019 Apr 25.

PMID:
31021538
24.

Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study.

Calvo A, Chiò A, Pagani M, Cammarosano S, Dematteis F, Moglia C, Solero L, Manera U, Martone T, Brunetti M, Balma M, Castellano G, Barberis M, Cistaro A, Artusi CA, Vasta R, Montanaro E, Romagnolo A, Iazzolino B, Canosa A, Carrara G, Valentini C, Li TQ, Nobili F, Lopiano L, Rizzone MG.

J Neurol. 2019 Jul;266(7):1633-1642. doi: 10.1007/s00415-019-09305-0. Epub 2019 Apr 4.

PMID:
30949819
25.

Molecular Profile of Advanced Non-Small Cell Lung Cancers in Octogenarians: The Door to Precision Medicine in Elderly Patients.

Fumagalli C, Catania C, Ranghiero A, Bosi C, Viale G, de Marinis F, Barberis M, Guerini-Rocco E.

J Clin Med. 2019 Jan 18;8(1). pii: E112. doi: 10.3390/jcm8010112.

26.

Diagnosis and first-line treatment of non-small cell lung cancer in the era of novel immunotherapy: recommendations for clinical practice.

De Marinis F, Barberis M, Barbieri V, Marchianò A, Gasparini S, Migliorino MR, Romano G, Spinnato F, Vitiello F, Gridelli C.

Expert Rev Respir Med. 2019 Mar;13(3):217-228. doi: 10.1080/17476348.2019.1569517. Epub 2019 Jan 24.

PMID:
30640563
27.

Effects of Non-Protein Amino Acids in Nectar on Bee Survival and Behavior.

Bogo G, Bortolotti L, Sagona S, Felicioli A, Galloni M, Barberis M, Nepi M.

J Chem Ecol. 2019 Mar;45(3):278-285. doi: 10.1007/s10886-018-01044-2. Epub 2019 Jan 6.

PMID:
30613849
28.

Metallaphotoredox-Catalyzed Cross-Electrophile Csp3-Csp3 Coupling of Aliphatic Bromides.

Smith RT, Zhang X, Rincón JA, Agejas J, Mateos C, Barberis M, García-Cerrada S, de Frutos O, MacMillan DWC.

J Am Chem Soc. 2018 Dec 19;140(50):17433-17438. doi: 10.1021/jacs.8b12025. Epub 2018 Dec 10.

29.

Predictive markers in lung cancer: a few hints for the practicing pathologist.

Barbareschi M, Barberis M, Buttitta F, Doglioni C, Fiorentino M, Fontanini G, Franco R, Marchetti A, Rossi G, Troncone G.

Pathologica. 2018 Mar;110(1):29-38. Review.

PMID:
30259911
30.

Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis.

Canosa A, Pagani M, Brunetti M, Barberis M, Iazzolino B, Ilardi A, Cammarosano S, Manera U, Moglia C, Calvo A, Cistaro A, Chiò A.

Eur J Neurol. 2019 Feb;26(2):306-312. doi: 10.1111/ene.13812. Epub 2018 Oct 24.

PMID:
30240096
31.

A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms.

Canosa A, De Marco G, Lomartire A, Rinaudo MT, Di Cunto F, Turco E, Barberis M, Brunetti M, Casale F, Moglia C, Calvo A, Marklund SL, Andersen PM, Mora G, Chiò A.

Neurobiol Aging. 2018 Dec;72:189.e11-189.e17. doi: 10.1016/j.neurobiolaging.2018.08.014. Epub 2018 Aug 24.

PMID:
30236613
32.

The immune profile of EGFR-mutated non-small-cell lung cancer at disease onset and progression after tyrosine kinase inhibitors therapy.

Fumagalli C, Guerini-Rocco E, Vacirca D, Passaro A, Marinis F, Barberis M.

Immunotherapy. 2018 Sep;10(12):1041-1045. doi: 10.2217/imt-2018-0027. No abstract available.

PMID:
30185137
33.

Predictable Irreversible Switching Between Acute and Chronic Inflammation.

Abudukelimu A, Barberis M, Redegeld FA, Sahin N, Westerhoff HV.

Front Immunol. 2018 Aug 7;9:1596. doi: 10.3389/fimmu.2018.01596. eCollection 2018.

34.

Simulation of Stimulation: Cytokine Dosage and Cell Cycle Crosstalk Driving Timing-Dependent T Cell Differentiation.

Barberis M, Helikar T, Verbruggen P.

Front Physiol. 2018 Aug 2;9:879. doi: 10.3389/fphys.2018.00879. eCollection 2018.

35.

A Mechanistic Computational Model Reveals That Plasticity of CD4+ T Cell Differentiation Is a Function of Cytokine Composition and Dosage.

Puniya BL, Todd RG, Mohammed A, Brown DM, Barberis M, Helikar T.

Front Physiol. 2018 Aug 2;9:878. doi: 10.3389/fphys.2018.00878. eCollection 2018.

36.

The multistep hypothesis of ALS revisited: The role of genetic mutations.

Chiò A, Mazzini L, D'Alfonso S, Corrado L, Canosa A, Moglia C, Manera U, Bersano E, Brunetti M, Barberis M, Veldink JH, van den Berg LH, Pearce N, Sproviero W, McLaughlin R, Vajda A, Hardiman O, Rooney J, Mora G, Calvo A, Al-Chalabi A.

Neurology. 2018 Aug 14;91(7):e635-e642. doi: 10.1212/WNL.0000000000005996. Epub 2018 Jul 25.

37.

A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.

Alvarez MJ, Subramaniam PS, Tang LH, Grunn A, Aburi M, Rieckhof G, Komissarova EV, Hagan EA, Bodei L, Clemons PA, Dela Cruz FS, Dhall D, Diolaiti D, Fraker DA, Ghavami A, Kaemmerer D, Karan C, Kidd M, Kim KM, Kim HC, Kunju LP, Langel Ü, Li Z, Lee J, Li H, LiVolsi V, Pfragner R, Rainey AR, Realubit RB, Remotti H, Regberg J, Roses R, Rustgi A, Sepulveda AR, Serra S, Shi C, Yuan X, Barberis M, Bergamaschi R, Chinnaiyan AM, Detre T, Ezzat S, Frilling A, Hommann M, Jaeger D, Kim MK, Knudsen BS, Kung AL, Leahy E, Metz DC, Milsom JW, Park YS, Reidy-Lagunes D, Schreiber S, Washington K, Wiedenmann B, Modlin I, Califano A.

Nat Genet. 2018 Jul;50(7):979-989. doi: 10.1038/s41588-018-0138-4. Epub 2018 Jun 18.

38.

Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.

De Luca C, Rappa AG, Gragnano G, Malapelle U, Troncone G, Barberis M.

J Clin Pathol. 2018 Aug;71(8):745-750. doi: 10.1136/jclinpath-2018-205197. Epub 2018 May 24.

PMID:
29798838
39.

Letter to the Editor.

Fumagalli C, Casadio C, Barberis M, Guarize J, Guerini-Rocco E.

Clin Lung Cancer. 2018 Jul;19(4):e439-e440. doi: 10.1016/j.cllc.2018.03.001. Epub 2018 Mar 12. No abstract available.

PMID:
29606366
40.

MicroRNA expression profile in primary lung cancer cells lines obtained by endobronchial ultrasound transbronchial needle aspiration.

Guarize J, Bianchi F, Marino E, Belloni E, Vecchi M, Donghi S, Lo Iacono G, Casadio C, Cuttano R, Barberis M, Di Fiore PP, Petrella F, Spaggiari L.

J Thorac Dis. 2018 Jan;10(1):408-415. doi: 10.21037/jtd.2017.12.69.

41.

Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.

Munzone E, Gray KP, Fumagalli C, Guerini-Rocco E, Láng I, Ruhstaller T, Gianni L, Kammler R, Viale G, Di Leo A, Coates AS, Gelber RD, Regan MM, Goldhirsch A, Barberis M, Colleoni M.

Breast Cancer Res Treat. 2018 Jul;170(2):351-360. doi: 10.1007/s10549-018-4767-1. Epub 2018 Mar 27.

PMID:
29589138
42.

Acquired Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers: The Role of Next-Generation Sequencing on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples.

Guerini-Rocco E, Passaro A, Casadio C, De Luca VM, Guarize J, de Marinis F, Vacirca D, Barberis M.

Arch Pathol Lab Med. 2018 Apr;142(4):465-473. doi: 10.5858/arpa.2017-0158-RA. Review.

PMID:
29565206
43.

The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics.

Fumagalli C, Vacirca D, Rappa A, Passaro A, Guarize J, Rafaniello Raviele P, de Marinis F, Spaggiari L, Casadio C, Viale G, Barberis M, Guerini-Rocco E.

J Clin Pathol. 2018 Sep;71(9):767-773. doi: 10.1136/jclinpath-2018-205032. Epub 2018 Mar 13.

PMID:
29535211
44.

GEMMER: GEnome-wide tool for Multi-scale Modeling data Extraction and Representation for Saccharomyces cerevisiae.

Mondeel TDGA, Crémazy F, Barberis M.

Bioinformatics. 2018 Jun 15;34(12):2147-2149. doi: 10.1093/bioinformatics/bty052.

PMID:
29401212
45.

Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?

Cavalcante P, Marcuzzo S, Franzi S, Galbardi B, Maggi L, Motta T, Ghislandi R, Buzzi A, Spinelli L, Novellino L, Baggi F, Antozzi C, Conforti F, De Pas TM, Barberis M, Bernasconi P, Mantegazza R.

Oncotarget. 2017 Sep 8;8(56):95432-95449. doi: 10.18632/oncotarget.20731. eCollection 2017 Nov 10.

46.

The role of multimodal treatment in patients with advanced lung neuroendocrine tumors.

Fazio N, Ungaro A, Spada F, Cella CA, Pisa E, Barberis M, Grana C, Zerini D, Bertani E, Ribero D, Funicelli L, Bonomo G, Ravizza D, Guarize J, De Marinis F, Petrella F, Del Signore E, Pelosi G, Spaggiari L.

J Thorac Dis. 2017 Nov;9(Suppl 15):S1501-S1510. doi: 10.21037/jtd.2017.06.14. Review.

47.

External quality assessment for EGFR mutations in Italy: improvements in performances over the time.

Normanno N, Fenizia F, Castiglione F, Barberis M, Taddei GL, Truini M, De Rosa G, Pinto C, Marchetti A.

ESMO Open. 2017 May 26;2(2):e000160. doi: 10.1136/esmoopen-2017-000160. eCollection 2017.

48.

Quantitative Systems Biology to decipher design principles of a dynamic cell cycle network: the "Maximum Allowable mammalian Trade-Off-Weight" (MAmTOW).

Barberis M, Verbruggen P.

NPJ Syst Biol Appl. 2017 Sep 19;3:26. doi: 10.1038/s41540-017-0028-x. eCollection 2017. Review.

49.

Metastatic and non-metastatic lymph nodes: quantification and different distribution of iodine uptake assessed by dual-energy CT.

Rizzo S, Radice D, Femia M, De Marco P, Origgi D, Preda L, Barberis M, Vigorito R, Mauri G, Mauro A, Bellomi M.

Eur Radiol. 2018 Feb;28(2):760-769. doi: 10.1007/s00330-017-5015-5. Epub 2017 Aug 23.

PMID:
28835993
50.

Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors.

Marchetti A, Barberis M, Franco R, De Luca G, Pace MV, Staibano S, Volante M, Buttitta F, Guerini-Rocco E, Righi L, D'antuono T, Scagliotti GV, Pinto C, De Rosa G, Papotti M.

J Thorac Oncol. 2017 Nov;12(11):1654-1663. doi: 10.1016/j.jtho.2017.07.031. Epub 2017 Aug 14.

Supplemental Content

Loading ...
Support Center